Patents
More topics under "C07J - Steroids" (42,482)
C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828)
C07J 11 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 3 (283)
C07J 13 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having a carbon-to-carbon double bond from or to position 17 (764)
C07J 15 - Stereochemically pure steroids containing carbon, hydrogen, halogen, or oxygen, having a partially or totally inverted skeleton, e.g. retrosteroids, l-isomers (136)
C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111)
C07J 19 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 by a lactone ring (362)
C07J 21 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring spiro-condensed with the cyclopenta[a]hydrophenanthrene skeleton (1,576)
C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033)
C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027)
C07J 33 - Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (413)
C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637)
C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516)
C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937)
C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565)
C07J 53 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms (1,809)
C07J 61 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms (90)
C07J 63 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms (2,707)
C07J 65 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of two rings, each by one atom (2)
C07J 67 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of two rings, each by one atom (2)
C07J 69 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of only one ring by one atom and expansion of only one ring by one atom (107)
C07J 7 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms (2,018)
C07J 71 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring (3,845)
C07J 73 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms (1,160)
C07J 75 - Processes for the preparation of steroids, in general (1,657)
C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897)
Patents for C07J - Steroids (408)
06/2003
06/05/2003US20030103864 Sterilization of pharmaceuticals
05/2003
05/27/2003US6569842 Method of preparing and use of prodrugs of betulinic acid derivatives
05/20/2003US6566542 Such as 17-alpha-fluoro-11-beta-(4-(2-(1-piperidinyl) ethoxy) phenyl)-estra-1,3,5(10)-trien-3-ol for treatment of osteoporosis and cardiovascular protection; side effect reduction; provides alternative to estradiol
05/14/2003EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
05/08/2003US20030086984 Treating collected plant material with a solvent to extract a fraction having appetite suppressant activity, separating extraction solution from plant material, removing the solvent from extraction solution and recovering
04/2003
04/16/2003EP1090027B1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
04/10/2003WO2003028735A1 Estrogen/gestagen combination preparation and application thereof
04/10/2003CA2462075A1 Estrogen/gestagen combination preparation and application thereof
02/2003
02/12/2003EP1023314B1 Bile acid salts of metals with physiological action and the use thereof in therapy
01/2003
01/30/2003US20030022874 New 17-halogenated 19-nor steroids, preparation process and intermediates, use as medicaments and the pharmaceutical compositions containing them
01/28/2003CA2094300C Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses
01/02/2003US20030004214 Irritable bowel disease
11/2002
11/14/2002US20020168427 Plant extract
09/2002
09/03/2002US6444649 Solid dispersion which comprises sialic acid derivative dispersed in water-soluble macromolecule
08/2002
08/29/2002WO2002041925B1 Sterilisation of pharmaceuticals
07/2002
07/23/2002US6423700 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
07/17/2002EP1222927A2 Pharmaceutical compositions having appetite suppressant activity
07/11/2002WO2002028880A8 Compounds useful for treating hypertriglyceridemia
07/04/2002WO2002022110A3 Contraception process and administration form for the same
06/2002
06/12/2002EP1213020A2 Pharmaceutical compositions having appetite suppressant activity
05/2002
05/30/2002WO2002041925A1 Sterilisation of pharmaceuticals
05/30/2002US20020065257 17beta-amino and hydroxylamino-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
05/02/2002US20020052352 Treating a malignant tumor, like a melanoma, using plant-derived compounds
04/2002
04/23/2002US6376657 Pharmaceutical compositions having appetite suppressant activity
04/11/2002WO2002028880A2 Compounds useful for treating hypertriglyceridemia
04/11/2002CA2424581A1 Compounds useful for treating hypertriglyceridemia
04/04/2002DE10045380A1 Verfahren zur Kontrazeption und dessen Darreichungsform Method of contraception and its dosage form
03/2002
03/27/2002EP0705273B1 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof
03/27/2002EP0705272B1 Novel process for preparing 17 beta-substituted 4-azaandrostane derivatives
03/21/2002WO2002022110A2 Contraception process and administration form for the same
02/2002
02/28/2002WO2002016395A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
01/2002
01/29/2002US6342489 Treatment of iron deficiency with ferric salt of bis hemisuccinylursodeoxycholic acid
01/09/2002CN1330659A Pregnane glucuronides compound
12/2001
12/12/2001CN1326461A Meiosis regulating compounds
11/2001
11/06/2001US6313142 Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
09/2001
09/19/2001CN1313862A Novel 17-halogenated 19-Nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
09/05/2001CN1311792A Meiosis regulating compound
08/2001
08/28/2001CA2191324C Process for preparing .delta.9,11 and 21-chloro corticosteroids
08/22/2001EP1125929A1 Method for making (-)-(2R,4S)-4-[(3,5-bis-trifluoromethyl-benzyl)-methoxycarbonylamino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester
08/09/2001WO2001056578A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
08/09/2001CA2396197A1 Use of rofleponide in the treatment of irritable bowel syndrome (ibs)
08/08/2001EP1121376A1 Pregnane glucuronides
08/01/2001CN1306432A Deoxy and oxygen-substituted sugar-contg. 14-aminosteriod compounds for use as antiarrhythmic
07/2001
07/25/2001CN1305489A Solid dispersion containing sialic acid derivative
07/17/2001US6262042 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/11/2001CN1303391A 17 Beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
07/11/2001CN1302800A Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
04/2001
04/11/2001EP1090027A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
03/2001
03/14/2001EP1082337A1 17 beta-amino and hydroxylamino-11 beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties
01/2001
01/24/2001EP1070725A1 Solid dispersion containing sialic acid derivative
01/16/2001US6174560 Substance for lowering high cholesterol level in serum and methods for preparing and using the same
01/16/2001CA2140345C Anti-inflammatory compounds for ophthalmic use
10/2000
10/31/2000US6140308 Colon or ileum-specific glucocorticosteroid derivatives
08/2000
08/02/2000EP1023314A1 Bile acid salts of metals with physiological action and the use thereof in therapy
05/2000
05/03/2000CN1252000A Pharmaceutical compositions having appetite suppressant activity
04/2000
04/20/2000WO2000021977A1 Pregnane glucuronides
04/20/2000CA2346693A1 Pregnane glucuronides
01/2000
01/26/2000EP0973534A1 Pharmaceutical compositions having appetite suppressant activity
01/18/2000US6015806 Topical use in the treatment of androgen-dependent diseases associated with the skin.
01/05/2000EP0969012A2 Process for preparing delta 9,11 and 21-chloro corticosteroids
01/05/2000EP0969011A2 Process for preparing delta 9,11 and 21-chloro corticosteroids
01/05/2000EP0763054B1 Process for preparing delta 9,11 and 21-chloro corticosteroids
01/04/2000US6011025 11-(substituted phenyl)-estra-4,9-diene derivatives
12/1999
12/29/1999WO1999067274A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/29/1999CA2336167A1 Novel 17-halogenated 19-nor steroids, method and intermediates for preparing same, use as medicines and pharmaceutical compositions containing same
12/09/1999WO1999062928A1 17β-AMINO AND HYDROXYLAMINO-11β-ARYLSTEROIDS AND THEIR DERIVATIVES HAVING AGONIST OR ANTAGONIST HORMONAL PROPERTIES
11/1999
11/30/1999US5994333 Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
11/18/1999CA2331962A1 Meiosis regulating compounds
11/10/1999EP0955049A2 6 Beta-Hydroxy - 6 alpha, 17 alpha - dimethylpregn - 4 ene - 3,20 - dione, as an inhibitor of smooth muscle proliferation
10/1999
10/21/1999WO1999052931A1 Solid dispersion containing sialic acid derivative
09/1999
09/28/1999US5958913 Administering saturated sterol fatty acid ester
09/21/1999US5955425 Parathyroid hormone analogues for the treatment of osteoporosis
08/1999
08/11/1999EP0678097B1 Novel colon- or ileum-specific steroid derivatives
07/1999
07/21/1999EP0565553B1 6,7-MODIFIED 11$g(b)-ARYL-4-ESTRENES
06/1999
06/02/1999EP0918527A1 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic
06/01/1999US5908833 Glucocorticosteroid chemically bound to a sugar
04/1999
04/22/1999WO1999019342A1 Bile acid salts of metals with physiological action and the use thereof in therapy
02/1999
02/25/1999WO1998046243A3 Pharmaceutical compositions having appetite suppressant activity
12/1998
12/09/1998CN1201038A Sulfurization for oestrogen mixture
12/09/1998CN1041095C Steroid compounds for treatment of prostatic hypertrophy, and its medicinal composition thereof
12/01/1998US5843931 6,7-modified 11β-aryl-4-oestrenes
11/1998
11/04/1998EP0875515A2 "Sulfatation of estrogen mixtures"
10/1998
10/28/1998EP0674651B1 Substituted 6-azaandrostenones
10/22/1998WO1998046243A2 Pharmaceutical compositions having appetite suppressant activity
10/22/1998CA2584411A1 Pharmaceutical compositions having appetite suppressant activity
10/14/1998CN1195666A Intermediates of steroids, their preparation and uses
09/1998
09/29/1998US5814624 Method for obtaining estrogens from pregnant mare urine by solid-phase extraction
09/16/1998EP0650496B1 Anti-inflammatory compounds for ophthalmic use
06/1998
06/02/1998US5760025 Administering testosterone 5a-reductase inhibitors
05/1998
05/12/1998US5750745 Process for preparing delta 9, 11 and 21-chlorocorticosteroids
03/1998
03/03/1998US5723454 Membrane filtration using adsoorber resin, washing with water and elution liquid, desorption with ether, alcohol or ketone
02/1998
02/11/1998CN1173181A Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function
02/10/1998US5717088 Method of making steroid derivatives for the treatment of prostatic hypertrophy
12/1997
12/24/1997WO1997048401A1 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic
12/24/1997CA2258202A1 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic
09/1997
09/10/1997EP0793967A2 Conjugated compounds of bile acids with thiotaurine and its N-alkyl derivatives
08/1997
08/06/1997EP0594612B1 A substance for lowering high cholesterol level in serum and a method for preparing the same
07/1997
07/23/1997EP0540717B1 UNSATURATED 17$g(b)-SUBSTITUTED 3-CARBOXY STEROIDS
06/1997
06/04/1997EP0559690B1 8-ENE-19, 11 beta-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM
06/04/1997CN1035055C Process for preparaing unsaturated 17-'beta' substituted 3-carboxysteroids
1 2 3 4 5